Scilex Holding Company Common Stock (SCLX) is a publicly traded Healthcare sector company. As of November 17, 2026, SCLX trades at $0.62 with a market cap of $8.79M and a P/E ratio of -0.11. SCLX moved -45.92% today. Year to date, SCLX is -95.41%; over the trailing twelve months it is -96.07%. Its 52-week range spans $0.58 to $34.27. Rallies surfaces SCLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Scilex delays third-quarter filing after auditor change: Scilex delayed its Form 10-Q for the quarter ended September 30, 2026, and does not expect to file within five calendar days of the deadline. It plans to file as soon as possible and anticipates no significant change in operating results from the year-earlier period; BPM’s prior audit reports flagged substantial doubt about Scilex’s ability to continue as a going concern.
| Metric | Value |
|---|---|
| Price | $0.62 |
| Market Cap | $8.79M |
| P/E Ratio | -0.11 |
| EPS | $-36.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $34.27 |
| 52-Week Low | $0.58 |
| Volume | 635.36K |
| Avg Volume | 0 |
| Revenue (TTM) | $30.25M |
| Net Income | $-362.25M |
| Gross Margin | 415.83% |
SCLX analyst coverage data. Average price target: $0.00.